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 Perceptions of people living with HIV and AIDS (PLHIV) about 
antiretroviral treatment (ART) is crucial for improving adherence. This study 
aims to examine the dynamics of perceptions during the early phase of ART. 
A longitudinal study involving newly diagnosed PLHIV was conducted. 
Interviews were carried out at the time of HIV diagnosis and at three months 
after ART initiation. Data were analyzed by comparing proportion of good 
perception across the continuum of HIV diagnosis, ART initiation and three-
months follow-up, and were tested using Chi-square. From 170 PLHIV 
participated in the study, 81.76% had initiated ART and 73.4% remained on 
ART at three-months of follow-up. Several positive perception items were 
significantly decreased: ability to take ART at work and ability to continue 
treatment if experiencing side effects, effectiveness of ART, confidentiality, 
unwanted disclosure, and level of support from outreach workers. Ability to 
follow instruction from physician was significantly increased, and negative 
attitudes toward ART were decreased across the continuum. Adherence to 
ART is a continuous process, and is influenced by the dynamics perceptions 
among PLHIV. Understanding these dynamics is crucial to formulate 
strategies that can promote and maintain positive attitudes toward ART as 
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1. INTRODUCTION  
Antiretroviral therapy (ART) is effective in suppressing viral load, slowing down disease progression, 
and preventing premature death among people living with HIV and AIDS (PLHIV) [1], [2]. The global AIDS 
mortality has declined from 1.2 million to 770,000 between 2010 and 2019 due to significant increase in access 
to ART [3]. Several studies have identified that the main contributor of AIDS-related deaths is limited access to 
ART or delayed ART initiation [4], [5]. The benefits of ART can only be maximized when it is promptly 
administered (early ART initiation) with high level of compliance [6]. The global HIV prevention strategy has 
emphasized the implementation of comprehensive and sustainable services for PLHIV [7], [8], requiring 
PLHIV to be aware of their status early, get immediate care and support, initiate early medication [9], and 
maintain high level of adherence towards their medication [9], [10].  
Indonesia has implemented the continuum of care and comprehensive health services for HIV (or 
locally called Layanan Komprehensif dan Berkelanjutan/LKB) since 2013. One pillar of this program is 
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sustainable comprehensive HIV services packages, including: HIV testing and counseling services, 
management of sexually transmitted infections (STIs), TB-HIV collaboration, prevention of mother-to-child 
transmission, anti retroviral (ARV) treatment and treatment for opportunistic infections [11]. HIV counseling 
program is expected to facilitate the establishment of self-efficacy, positive perceptions about HIV treatment 
and care, and to reduce self-stigma. The primary objective is to increase the uptake of HIV testing and early 
ART initiation, as well as to improve adherence to ART [11].  
Perceptions of PLHIV about ART are influenced by various factors including provider-related 
issues, stigma or fear of discrimination, and comprehensive understanding about benefits and side effects of 
ART. For instance, the acceptance of early ART initiation is influenced by the trust of PLHIV towards 
healthcare providers (e.g. doctors and clinic staff) where treatment is being offered [6], [12]-[14]. Trust of 
PLHIV toward health workers and facilities can be strengthen by promoting practices that maintain 
confidentiality and by providing non-discriminatory services or non-stigmatizing attitudes [13], [15]. 
Similarly, fear of side effects or treatment failure and considerations regarding harms and benefits of ART 
have been identified by many scholars as contributing factors for accepting or rejecting early ART initiation 
[12], [16]-[18]. PLHIV with good understanding about drug efficacy [19] and strong confidence in the ability 
to take medication regularly [12], [20] are more likely to accept ART. Furthermore, the long-term adherence 
towards ART is influenced positively by good interpersonal relationships with health providers in conducive 
clinical environments [12], adequate management of side effects [12], [21], sufficient availability of complex 
treatment modalities [12], and constructive experiences with social support systems [2].  
Perceptions of PLHIV regarding ART, access to care and quality of health services may change over 
the course of the treatment. However, this is yet to be observed from existing studies where many are cross-
sectional in nature, capturing only a single event or phenomenon during the continuum of HIV treatment. We 
reported the changes in perceptions among PLHIV from a longitudinal study. This study investigated the 
dynamics of perceptions of PLHIV at three different points: at initial HIV diagnosis, at ART initiation, and at 
three months after ART initiation. Understanding the dynamics of perceptions among PLHIV throughout the 
HIV care continuum, especially over the course of anti retroviral (ARV) medication is crucial to better design 
strategies, including HIV counselling methods and contents as well as related prevention strategies for 
improving long-term adherence towards ART. 
 
 
2. RESEARCH METHOD 
 This study was conducted at the WM Medika Clinic, an outpatient HIV and sexual health clinic at 
Kerti Praja Foundation (KPF) in Bali Province, Indonesia. KPF is a non-profit organization providing 
comprehensive HIV services which includes: HIV prevention through outreach and health promotion; HIV 
and ART counseling; diagnostic tests; treatment of sexually transmitted infections including HIV-AIDS; 
mitigation activities; and social support. These services are provided to the general population and key 
affected population groups such as female sex workers (FSW), men who have sex with men (MSM), people 
who inject drugs (PWID), and transgender women (waria).  
The outreach activities at KPF are performed by outreach workers (OWs) to promote HIV prevention 
behaviors and to increase HIV testing coverage, especially among key populations. Clinic doctors and OWs are 
also trained as HIV counselors using the HIV counselling and testing training modules recommended by the 
Ministry of Health (MOH) [22]. HIV-positive clients are provided with general information about ART and 
HIV prevention, and are offered early ART initiation by OWs. Those who accept to initiate ART are referred to 
the doctor in the clinic for comprehensive health assessment prior to ART initiation and to provide clients with 
complete information regarding benefits, side effects and the importance of adherence to the treatment.  
The study employed a longitudinal quantitative observational design with a cohort of newly-diagnosed 
HIV patients starting from 15 October 2015. These patients were followed until January 31, 2017. At the time 
of diagnosis, all PLHIV aged ≥18 years-old were offered ART and were asked to participate in the study. 
Written consent was obtained from those who agreed to participate in the study. They were interviewed by the 
research team to explore their perceptions about ART and the quality of services they had received at the time of 
HIV diagnosis, at ART initiation, and at three months after the initiation. For the purpose of this study, a 
maximum of three months was given to PLHIV either to accept or to decline the treatment [23]. We collected 
the data at three occasions referred here as T1, T2, and T3. T1 was a point when patients were firstly diagnosed 
with HIV; T2 was a point of ART initiation; and T3 was a point of three months of follow-up after ART 
initiation. The last date of ART initiation was on September 24, 2016. Subsequent observations after this date 
were made only to PLHIV who accepted and initiated ART. The first interview was conducted at the beginning 
of the study (T1, n=170), and the second interview was conducted at three-months after ART initiation (T3, 
n=102) to re-evaluate their perceptions about the treatment and the quality of health services they had received. 
No interview was performed at the ART initiation (T2). Perceptions of PLHIV who finally accepted and 
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initiated ART (T2, n=139) were extrapolated from the first interview data (by excluding data of those who 
declined the treatment, n=31). The last date of the three-month follow-up was on November 26, 2016.  
We used a structured questionnaire to assess perceptions of PLHIV. This questionnaire was pre-
tested among PLHIV and the revised version was used in this study. Data were collected through structured 
interviews using this questionnaire. The interviews were performed by trained enumerators which included 
17 OWs and three research assistants. At T1, interviews were conducted by OWs for the convenient of the 
patients because OWs usually accompanied the patients when they received their HIV diagnosis. At T3, 
interviews were performed by research assistants.  
We assessed perceptions of PLHIV in seven domains; each domain consists of 3-7 items. These 
domains (or sub-perception categories) included: perceptions of being able to take medication (seven items), 
positive attitudes toward ART (six items), negative perceptions toward ART (four items), perceptions 
towards doctors (four items), perceptions towards OWs (four items) and perceptions about the clinic (three 
items). Each item was rated on a scale of 1 to 4, with „1‟ as being „unsure‟ and „4‟ as being very confident. A 
cumulative score was generated for each sub-perception category. Because of the data were not normally 
distributed, we used the median value to categorize perception into „good perception‟ (≥median) and „poor 
perception‟ (<median). The acceptance of ART at T2 was defined as „accept‟ when PLHIV have commenced 
ART and as „not accept‟ if they refused the treatment or did not provided a response to the ART offer within 
three months of their diagnosis. We also explored socio-demographic characteristics of PLHIV. 
Quantitative analysis was conducted by categorizing perception items based on the median value; 
and was compared using the median test between two-three times of measurement (T1, T2 and T3). Each 
sub-item of perceptions was compared using Chi-square test, between T1, T2 and T3. Socio-demographic 
characteristics were also compared in three times of T1, T2, and T3. All analyses were performed using 
STATA 12 (StataCorp LLC, Texas, USA). 
The study was approved by the Human Research Ethics Committee, Faculty of Medicine Udayana 
University–Sanglah General Hospital on October 5, 2015 (Protocol Number: 1649/UN.14.2/Litbang/2015). 





A total of 189 newly diagnosed PLHIV were offered to initiate ART and were invited to participate 
in the study. Of 170 (89.9%) who agreed to participate in the study, a total of 139 (81%) accepted ART. 
Three months after ART initiation as many as 102 (73.3%) PLHIV remained on ART. A total of 170 
respondents were successfully interviewed at T1 (at the time of HIV diagnosis) and 102 respondents at T3 
(three months after ART initiation).  
 
3.1.  Socio-demographic characteristics 
Table 1 depicts socio-demographic characteristics of PLHIV at the time of HIV diagnosis (T1) and 
those who initiated ARV treatment (T2). In terms of socio-demographic characteristics, we found no significant 
difference between the two groups (T1 vs T2). The majority of PLHIV (both in T1 and T2) were male, with an 
average age of 30 years, highly educated, employed, middle income, unmarried, and the majority were MSM. 
 
 
Table 1. Socio-demographic characteristics of PLHIV 
Characteristics T1 (n=170) T2 (n=139) T3 (n=102) p p 
 n % n % n % T1-T2 T2-T3 
Sex Female 55 32.35 43 30.9 30 29.41 0.782 0.804 
Male 115 67.65 96 69.1 72 70.59 0.658 0.804 
Educational level  Illiterate-elementary school 35 20.59 25 17.98 18 17.65 0.563 0.538 
Junior high school 25 14.71 22 15.82 14 13.73 0.790 0.653 
High school and university 110 64.71 92 66.19 70 68.63 0.784 0.690 
Employment status Unemployed 23 13.53 19 14.00 15 14.70 0.730 0.878 
Employed 147 86.70 120 86.00 87 85.29 0.858 0.876 
Marital status Not married 97 57.06 83 59.70 62 60.78 0.640 0.866 
Married 28 16.47 23 16.55 16 15.69 0.959 0.858 
Widowed/divorced 45 26.47 33 23.75 24 23.53 0.583 0.968 
Risk group Heterosexual  27 15.88 25 17.96 16 15.69 0.627 0.643 
FSW 45 26.47 33 23.74 21 20.59 0.583 0.562 
Homosexual and bisexual 98 57.65 81 58.30 53 51.97 0.909 0.329 
Age Median (IQR) (year) 30.1 (10.9) 29.7 (8.9) 30.0 (11.3) 0.933 0.943 
Salary  Median (IQR) (million, IDR) 2.0 (1.5) 2.0 (1.5) 2 (1.5) 1.000 1.000 
Work duration Median (IQR) (year) 2.0 (3) 2.0 (3) 2.0 (3) 1.000 1.000 
*Two proportion test and median test were used, alpha 0.05; **part of sociodemographic characteristics were presented in related article [24] 
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3.2.  Perceptions of PLHIV at the beginning of the study (T1), ART initiation (T2) and three months 
after ART initiation (T3) 
Table 2 present the dynamics of perceptions among PLHIV about ART and the quality of HIV-
related services they had received at three different times. The median values of positive perceptions toward 
ART, negative attitudes toward ARV and perceptions toward the clinic were significantly differed between 
T1 (HIV diagnosis, n=170) and T2 (ART initiation, n=139). It signals that perceptions about ARV drug and 
the quality of HIV-related services, particularly toward the clinic, have significantly influenced the decisions 
of PLHIV to initiate early ART. 
 
 
Table 2. Proportion of good perceptions about ART and HIV-related services received by PLHIV at the time 
of HIV diagnosis (T1), ART initiation (T2) and three months after ART initiation (T3)  







Perception of ability to take ARV (median, IQR) 23 (5) 23 (6) 21 (3) 0.115 0.000 0.006 
Collect medication monthly 94.70 96.40 97.06 0.475 0.359 0.778 
Follow physician‟s instructions 90.59 88.80 98.04 0.605 0.017* 0.006* 
Consume medication on schedule 95.30 96.40 94.12 0.632 0.670 0.402 
Consume medication at workplace 92.36 94.96 78.43 0.355 0.001* 0.000* 
Consume medication during travel 92.94 94.97 95.10 0.460 0.476 0.963 
Consume medication during illness 90.59 93.52 94.12 0.348 0.301 0.849 
Continue medication when experiencing side effects 95.30 98.56 92.16 0.107 0.287 0.014* 
Positive beliefs of ARV (median, IQR) 18 (4.3) 19 (5) 17 (5.0) 0.000 0.263 0.000 
ARV can improve overall health  91.76 95.69 93.14 0.162 0.680 0.386 
ARV increases the longer life expectancy 90.00 92.09 90.19 0.524 0.960 0.605 
ARV increases the possibility to work normally 91.76 94.25 91.17 0.397 0.867 0.356 
ARV prevents progression to AIDS 89.42 92.09 92.15 0.423 0.458 0.986 
ARV reduces the number of virus in the body 90.00 92.08 83.33 0.526 0.107 0.036* 
ARV increases immunity 90.00 93.53 85.29 0.266 0.243 0.035* 
Negative beliefs of ARV (median, IQR) 10 (4.0) 10 (3) 6 (1) 0.010 0.000 0.000 
ARV increases possibility of hospitalization 68.82 70.50 2.94 0.750 0.000* 0.000* 
ARV causes severe side effects  32.35 30.93 73.52 0.790 0.000* 0.000* 
ARV increases risk for tuberculosis, rhinitis, diarrhea 39.42 39.56 4.90 0.980 0.000* 0.000* 
ARV causes unwanted disclosure of HIV status  74.12 74.82 8.82 0.888 0.000* 0.000* 
Perception to Physician (median, IQR)  13 (4.0) 13 (4.0) 13 (4.0) 0.514 0.826 0.432 
Physicians suggest the best option 98.14 98.56 97.06 0.775 0.562 0.419 
Physicians provide good service 98.24 97.84 98.04 0.780 0.905 0.914 
Physicians maintain confidentiality 95.29 96.41 92.16 0.626 0.288 0.149 
Physicians are supportive of treatment 99.42 99.28 100.00 0.878 0.441 0.391 
Perception to Outreach Workers (median, IQR) 16 (4.0) 16 (4.0) 15 (5.0) 0.387 0.003 0.033 
OWs maintain confidentiality  97.65 97.84 87.25 0.911 0.001* 0.001* 
OWs treat PLHIV equally with other patients 95.29 96.40 94.12 0.629 0.673 0.149 
OWs are prepared to assist with ARV issues  98.82 99.28 97.05 0.682 0.294 0.181 
OWs are prepared to support other problems 91.17 90.65 69.60 0.874 0.000* 0.000* 
OWs remind PLHIV to take their medication 96.47 96.40 90.19 0.974 0.033 0.049* 
Perception toward KPF Clinics (median, IQR) 9 (3.0) 10 (3.0) 9 (2.0) 0.000 0.093 0.000 
KPF is appropriate for ART 97.65 98.56 97.06 0.564 0.766 0.420 
KPF maintains confidentiality of PLHIV 95.88 97.13 95.1 0.555 0.762 0.411 
KPF is well-equipped with necessary facilities 95.29 94.96 92.16 0.893 0.288 0.374 
*Significant at p<0.05, T1= PLHIV agree to participate in study, T2 = PLHIV who initiate ART, T3 = PLHIV who remained on ART 
three months after ART initiation 
 
 
In addition, perceptions of PLHIV were varied between those who were offered ART (T1, n=170) 
and those who remained on ART after three-months of follow-up (T3, n=102). Similarly, perceptions of 
PLHIV who accepted and initiated ART (T2, n=139) and those who remained on ART after three months of 
follow-up (T3, n=102) were also significantly differed. These findings suggest that adherence towards ART 
might be influenced by perceptions of PLHIV about ART and the quality of HIV-related services they had 
received.  
In terms of the perceived ability to take ART, we found three items that might influence adherence 
towards ART which include: (1) „ability to follow physician‟s instruction‟; (2) „ability to consume 
medication at the workplace‟; and (3) „ability to continue consuming medication when experiencing side 
effects‟. PLHIV who remained on ART after three months of follow-up (T3) have higher confidence about 
their ability to follow physician‟s instructions. However, their perceived ability to be able to consume ART at 
workplace and to continue taking ART while experiencing side effects were significantly lower compared to 
at the time of HIV diagnosis (T1) or at ART initiation (T2).  
We identified that positive beliefs about ART (i.e. „ARV reduces number of virus in the body‟ and 
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„ARV increases immunity‟) among PLHIV who accepted and initiated ART (T2) were significantly higher 
than those who remained on ART after three months of follow-up (T3). Similarly, we found that negative 
perceptions among PLHIV about ART were decreased significantly from T1 to T3. Perceptions of PLHIV 
about the physician and clinic remained relatively constant across the three points (T1, T2 and T3). However, 
we observed that three out of five items of perceptions toward OWs were decreased significantly across the 
three points. These items included: „OWs maintain confidentiality‟; „OWs are prepared to support PLHIV 




The current study is the first to examine the dynamics of perceptions of newly diagnosed HIV 
patients until three months of follow-up after ART initiation. Previous studies fail to capture such dynamics 
because they only provide a „snapshot‟ of perceptions using cross-sectional analysis [25]. Our study 
addresses this knowledge gap through longitudinal study with serial analysis at the time of HIV diagnosis, at 
ART initiation, and at three months after ART initiation. 
Our study found that newly diagnosed HIV patients and PLHIV who accepted and initiated ART 
have high level of positive attitudes about their ability to take medication, effectiveness of ART, health 
providers and the quality of HIV-related services they had received. However, after three months on ART 
their perceptions had changed. Our serial analysis revealed small fluctuations of perceptions at the beginning 
of HIV diagnosis, at ART initiation and three months after ART initiation. However, it is sufficient to signal 
that adherence to ART is a continuous process. Positive experiences and supportive environment are likely to 
enable PLHIV to comply with their medication plan.  
At the beginning of the treatment, we found that PLHIV have strong perceptions about their ability 
to take a lifetime medication and to manage side effects of the treatment. These strong perceptions are 
contributed by their understanding about ART provision [26], [27], adverse effects of the treatment [28], 
[29], and their self-worth and self-efficacy [12], [20], [30]. However, after on ART for three months, these 
positive attitudes were decreased significantly, especially with regard to their ability to take medication 
regularly at workplace and their ability to continue medication if they experience side effects. These findings 
are consistent with other study which found that PLHIV face difficulties to take pills daily and to manage 
their medication schedule with other daily activities [21], mainly if they were afraid of stigma or unwanted 
disclosure [12], [31], [32]. While the introduction of single dose drugs (oral or injectable) [33], [34] could 
address such issue, these modalities are currently not available in our study location. However, we observed 
an increase perceived ability to follow instructions from physician after being on ART for three months. 
Arguably, this might be attributed by supportive and conducive environment from health providers at the 
clinic. 
Our study identified that negative perceptions about ART were high following the HIV diagnosis, 
especially the perception that „ART will cause unwanted disclosure of HIV status‟. This indicates that 
disclosure or stigma remains a major concern of many newly diagnosed HIV patients [12], [18], [32], [35]-
[37]. It can be argued that many „at risk‟ individuals might share the same perception about HIV testing and 
unwanted disclosure leading to low coverage of HIV counselling and testing [36]. However, three months 
after ART initiation, our analysis found that these negative perceptions were significantly decreased to <10%. 
This finding is promising and is consistent with findings from other studies [13], [38]. Positive experiences 
throughout the treatment alongside non-discriminatory care relationships between PLHIV and health 
providers have enabled trust formation that their privacy and confidentiality are protected.  
In addition, almost one-third of our research participants were anxious about negative effects of 
ART at the time of HIV diagnosis. It is quite common for newly diagnosed HIV patients to feel worried 
about side effects, long-term risks and treatment failure [28]. Negative perceptions toward certain medication 
could outweigh the actual tolerability to such medication [29] leading to higher risk of experiencing side 
effects. Our serial analysis showed a two-fold increase of negative perceptions towards side effects after 
being on ART for three months, which could influence their adherence to ART. It is important to note that 
13.5% of PLHIV in our study discontinued their medication due to side effects of the treatment, as also 
reported in various studies [39], [40]. Even after three-months of follow-up, we found that 27.6% of PLHIV 
continued to experience side effects from the treatment and they remained on ART regardless of the side 
effects. Maintaining positive attitudes toward ART by leveraging positive care relationships between PLHIV 
and health providers, conducive and non-discriminatory health services, and delivering positive messages 
through formal and informal communication strategies [36] is crucial to improve treatment adherence. 
Perceptions of PLHIV toward physicians, the clinic and the quality of HIV-related care they had 
received were relatively positive and stable throughout the continuum of HIV diagnosis, ART initiation and 
three-month follow-up, except for the outreach workers. Many studies have investigated the roles of 
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physician in improving self-efficacy and adherence towards ART [20], [37], [41]-[43]; as well as the roles of 
clinic (or other healthcare facilities) in improving compliance towards HIV medication [12]-[14]. While the 
roles of health provider in general have been discussed in the literature [44], to the best of our knowledge, 
there is no existing study ever discusses the roles of outreach workers in improving self-efficacy of PLHIV 
and ART adherence. Our study addresses this gap by providing the crucial roles and positions of outreach 
workers, the backbone of HIV prevention, care and treatment in Indonesia, in improving self-efficacy of 
PLHIV and adherence to ART. Additionally, outreach workers are the primary contact for key population 
groups who require HIV testing, and for newly diagnosed HIV patients who decided to start medication. Our 
study found that perceptions of PLHIV toward outreach workers were highly positive at the time of HIV 
diagnosis; however, it was significantly decreased over time particularly with regard to confidentiality issues 
and the level of support provided by outreach workers. In addition, this finding supports the important aspect 
of counseling to communicate deeply about ARV drug with PLHIV to increase the successful of counseling 
provided by outreach workers [24]. 
The substantial decrease of PLHIV throughout the continum of HIV diagnosis (T1, n=170), ART 
initiation (T2, n=139), and three months follow-up (T3, n=102) suggests that adherence to ART is a 
continuous process which is influenced by the dynamics of perceptions of PLHIV about ART and the quality 
of HIV-related services they had received. Promoting positive perceptions during HIV counseling and testing 
is just as crucial as maintaining positive attitudes and experiences at ART initiation and throughout the 
treatment [23], [36], [45]. The three-months follow-up is particularly critical when positive perceptions have 
started to decrease while at the same time some negative attitudes have started to develop. 
The present study has several limitations. First, the instrument used to capture perceptions of PLHIV 
was developed based on the health belief model (HBM) framework. It requires comprehension and prior 
knowledge about HIV and/or ART to be able to respond accurately to the questions/statements, which in 
some cases can be very challenging for PLHIV. Second, the dynamics of perceptions were only collected 
from PLHIV who remained on ART after three months of follow-up. They are more likely to have more 
positive attitudes and relatively stable perceptions over the continuum of HIV diagnosis, ART initiation and 
follow-up. Third, at the time of HIV diagnosis, PLHIV were interviewed by their outreach workers for the 
convinient of the participants. However, this strategy might create social desirability effect for which 
participants provide answers/responses to please the interviewer. Lastly, we recruited our study participants 
using a consecutive selection process which is vulnerable to selection bias, and therefore reducing the 




Adherence to ART is a continuous process influenced by the dynamics of perceptions among 
PLHIV related to their HIV diagnosis, ART and the quality of HIV-related care they had received from 
healthcare facilities. Understanding these dynamics is crucial to design, formulate and implement strategies 
that can promote and maintain positive attitudes toward ART as well as living with HIV more broadly, 
particularly among key population groups who might experience social exclusion from the society. Further 
studies should be done to encounter several limitations in this study, such as simplified the questionnaire, 
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